Cost–utility analysis of germline BRCA1/2 testing in women with high‑grade epithelial ovarian cancer in Spain
Palabras clave :
Materias Investigacion::Ciencias de la Salud::Oncología
BRCA1 gene
BRCA2 gene
Cancer screening test
Cost–utility analysis
Ovarian cancer
Quality-adjusted life years
Fecha de publicación :
2019
Editorial :
Springer Science and Business Media LLC
Nota:
This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
Cita:
Moya‑Alarcón, C. (Carlota); González‑Domínguez, A. (Almudena); Simón, S. (Susana); et al. "Cost–utility analysis of germline BRCA1/2 testing in women with high‑grade epithelial ovarian cancer in Spain". Clinical and Translational Oncology. 21, 2019, 1076 - 1084
Aparece en las colecciones:
Estadísticas e impacto
0 citas en
0 citas en
Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.